These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1446971)

  • 1. Conformationally biased analogs of oxytocin.
    Lebl M; Toth G; Slaninová J; Hruby VJ
    Int J Pept Protein Res; 1992 Aug; 40(2):148-51. PubMed ID: 1446971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally restricted analogs of oxytocin; stabilization of inhibitory conformation.
    Lebl M; Hill P; Kazmierski W; Kárászová L; Slaninová J; Fric I; Hruby VJ
    Int J Pept Protein Res; 1990 Oct; 36(4):321-30. PubMed ID: 2079387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1.
    Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J
    J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-phase synthesis and biological activity of the parallel dimer of deamino-oxytocin.
    Munson MC; Lebl M; Slaninová J; Barany G
    Pept Res; 1993; 6(3):155-9. PubMed ID: 8318747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of changing the COOH-terminal amide group present in the hydrophilic cluster of oxytocin to dimethylamide.
    Ting YF; Smith CW; Stahl GL; Walter R; Cordopatis P; Theodoropoulos D
    J Med Chem; 1980 Jun; 23(6):693-5. PubMed ID: 7392037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
    Flouret G; Chaloin O; Slaninová J
    J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogs of oxytocin containing a pseudopeptide Leu-Gly bond of cis and trans configuration.
    Lebl M; Slaninová J; Johnson RL
    Int J Pept Protein Res; 1989 Jan; 33(1):16-21. PubMed ID: 2722396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of modification at position 2 on the side-chain conformation in oxytocin analogs.
    Smiech B; Kaźmierkiewicz R; Lammek B
    Acta Biochim Pol; 2006; 53(1):113-20. PubMed ID: 16523218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z; Lammek B; Gazis D; Schwartz IL
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin analogs effective as noncompetitive inhibitors in uterotonic test.
    Lebl M; Bojanovska V; Barth T; Jost K
    Experientia; 1978 Dec; 34(12):1543-5. PubMed ID: 729711
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of methylated phenylalanines via hydrogenolysis of corresponding 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids. Synthesis and biological activity of oxytocin analogs with methylated phenylalanines in position 2.
    Majer P; Slaninová J; Lebl M
    Int J Pept Protein Res; 1994 Jan; 43(1):62-8. PubMed ID: 8138352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic antagonists of in vivo responses by the rat uterus to oxytocin.
    Lowbridge J; Manning M; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1979 May; 22(5):565-9. PubMed ID: 458806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some pharmacological properties of cyclic and linear analogs obtained by substituting each residue of an oxytocin antagonist with D-tryptophan.
    Flouret G; Brieher W; Majewski T; Mahan K; Wilson L
    Int J Pept Protein Res; 1991 Aug; 38(2):169-75. PubMed ID: 1783491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin analogs with oxygen-containing side chains in position 3.
    Gazis D; Schwartz IL; Cordopatis P; Theodoropoulos D
    Int J Pept Protein Res; 1986 Jun; 27(6):679-84. PubMed ID: 3759339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
    Stahl GL; Walter R
    J Med Chem; 1977 Apr; 20(4):492-5. PubMed ID: 850233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
    Manning M; Lowbridge J; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1978 Feb; 21(2):179-82. PubMed ID: 621712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and some pharmacological properties (4-beta-(2-thienyl)-L-alanine)oxytocin.
    Smith CW; Skala G; Walter R
    J Med Chem; 1978 Jan; 21(1):115-7. PubMed ID: 619140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desaminopenicillamine tocinoic acid derivatives--inhibitors of oxytocin.
    Roy U; Gazis D; Glass JD; Schwartz IL
    Int J Pept Protein Res; 1986 Aug; 28(2):154-62. PubMed ID: 3771100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7.
    Fragiadaki M; Magafa V; Borovicková L; Slaninová J; Cordopatis P
    Eur J Med Chem; 2007 Jun; 42(6):799-806. PubMed ID: 17316912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkylating analogs of bradykinin.
    Turk J; Needleman P; Marshall GR
    J Med Chem; 1975 Nov; 18(11):1135-9. PubMed ID: 240938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.